Three Dimensional Ultrasonographic Detection of Human Ovulation

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Ovulation Disorder
Interventions
DRUG

Indomethacin 50 MG

The medication is commenced when a preovulatory follicle is observed. It will be administered for a minimum of one day, up to a maximum of 7 days. It will be discontinued when anovulation is observed.

PROCEDURE

Transvaginal ultrasound scans

Ultrasound scans done intermittently before and after an ovulatory or anovulatory event

DIAGNOSTIC_TEST

Finger prick blood test

Capillary blood extracted from a finger prick. Blood spots are collected on a specialized card, dried and frozen before reproductive hormones are assayed from them.

DIAGNOSTIC_TEST

Urine test

Early morning urine tests to assay reproductive hormones

Trial Locations (1)

S7N0W8

RECRUITING

Department of Obstetrics, Gynecology and Reproductive Sciences, University of Saskatchewan, Saskatoon

All Listed Sponsors
lead

University of Saskatchewan

OTHER